Streetbeat News

Price Targets

HIPO

Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith maintains an Outperform rating on Hippo Holdings (NYSE:HIPO) but lowers the price target from $19 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 4:15 pm

ASH

BMO Capital analyst John McNulty has maintained a Market Perform rating on Ashland (NYSE:ASH) and reduced the price target from $84 to $75.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 4:12 pm

VIPS

Vishop Holdings' stock is trading higher following an upgrade by Citigroup from Neutral to Buy, along with an increase in the price target from $18 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 4:06 pm

VFC

V.F. Corporation (VFC) shares are experiencing an uptick following an upgrade by JP Morgan from Underweight to Neutral, accompanied by a price target increase from $15 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 4:04 pm

STRO

Over the past 3 months, 6 Wall Street analysts have provided ratings for Sutro Biopharma (NASDAQ:STRO), with 3 giving a bullish and 3 a somewhat bullish rating. The average 12-month price target for STRO is $14.5, with a high of $25.00 and a low of $10.00, representing a 19.44% decrease from the previous target of $18.00. Analysts rate stocks to predict their performance and provide guidance to investors.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 4:00 pm

YPF

Within the last quarter, YPF (NYSE:YPF) received 4 analyst ratings, with 3 being bearish and 1 indifferent. The 12-month price target for YPF averages $10.2, with a high of $14.50 and a low of $8.30. This target has increased by 21.86% over the past month. Analyst ratings are based on information from company calls, financial statements, and insider conversations.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 4:00 pm

ALNY

Alnylam Pharmaceuticals (NASDAQ:ALNY) has received a mix of bullish and indifferent analyst ratings over the last quarter, with no bearish ratings. The average 12-month price target among 20 analysts is $252.65, with a high of $405.00 and a low of $170.00. This target has increased by 1.47% from the previous target of $249.00. Analysts rate stocks based on research and provide guidance which investors should use with caution, as analysts are also human and can only offer opinions.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 4:00 pm

TXN

Over the past 3 months, 16 analysts have provided their ratings on Texas Instruments (NASDAQ:TXN), with an average 12-month price target of $170.5, a decrease of 6.36% from the previous target of $182.08. Ratings include 3 bullish, 5 somewhat bullish, 3 indifferent, 3 somewhat bearish, and 2 bearish. Analysts' ratings are based on company analysis and are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 4:00 pm

IHRT

iHeartMedia (NASDAQ:IHRT) has received mixed analyst ratings in the last quarter with 1 bullish, 1 indifferent, and 2 somewhat bearish ratings. The average 12-month price target among 4 analysts is $3.73, which is a 36.56% decrease from the previous target of $5.88. The high target is $7.00 and the low target is $2.00.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 4:00 pm